Sunday, September 28, 2025
Science
No Result
View All Result
  • Login
  • HOME
  • SCIENCE NEWS
  • CONTACT US
  • HOME
  • SCIENCE NEWS
  • CONTACT US
No Result
View All Result
Scienmag
No Result
View All Result
Home Science News Medicine

A revised classification of primary iron overload syndromes

April 29, 2024
in Medicine
Reading Time: 3 mins read
0
A Revised Classification of Primary Iron Overload Syndromes
65
SHARES
593
VIEWS
Share on FacebookShare on Twitter
ADVERTISEMENT

The clinical introduction of hepcidin25 (Hep25) has led to a more detailed understanding of its relationship with ferroportin (FP) and divalent metal transporter1 in primary iron overload syndromes (PIOSs). In 2012, we proposed a classification of PIOSs based on the Hep25/FP system, which consists of prehepatic aceruloplasminemia, hepatic hemochromatosis (HC), and posthepatic FP disease (FP-D). However, in consideration of accumulated evidence on PIOSs, we aimed to renew the classification.

A Revised Classification of Primary Iron Overload Syndromes

Credit: Hisao Hayashi

Background and Aims

The clinical introduction of hepcidin25 (Hep25) has led to a more detailed understanding of its relationship with ferroportin (FP) and divalent metal transporter1 in primary iron overload syndromes (PIOSs). In 2012, we proposed a classification of PIOSs based on the Hep25/FP system, which consists of prehepatic aceruloplasminemia, hepatic hemochromatosis (HC), and posthepatic FP disease (FP-D). However, in consideration of accumulated evidence on PIOSs, we aimed to renew the classification.

 

Methods

We reviewed the 2012 classification and retrospectively renewed it according to new information on PIOSs.

 

Results

Iron-loading anemia was included in PIOSs as a prehepatic form because of the newly discovered erythroferrone-induced suppression of Hep25, and the state of traditional FP-D was remodeled as the BIOIRON proposal. The key molecules responsible for prehepatic PIOSs are low transferrin saturation in aceruloplasminemia and increased erythroferrone production by erythroblasts in iron-loading anemia. Hepatic PIOSs comprise four genotypes of HC, in each of which the synthesis of Hep25 is inappropriately reduced in the liver. Hepatic Hep25 synthesis is adequate in posthepatic PIOSs; however, two mutant FP molecules may resist Hep25 differently, resulting in SLC40A1-HC and FP-D, respectively. PIOS phenotypes are diagnosed using laboratory tests, including circulating Hep25, followed by suitable treatments. Direct sequencing of the candidate genes may be outsourced to gene centers when needed. Laboratory kits for the prevalent mutations, such as C282Y, may be the first choice for a genetic analysis of HC in Caucasians.

 

Conclusions

The genetic background of PIOS differs in Caucasians and non-Caucasians.2 Therefore, physicians have to overcome differences in the global prevalence of PIOS in clinical practice. The Hep25/FP system classifies PIOSs as prehepatic ACP and ILA, hepatic HC, and posthepatic SLC40A1-HC and FP-D. The revised classification for PIOSs may be useful worldwide.

 

Full text

 

The study was recently published in the Journal of Clinical and Translational Hepatology.

The Journal of Clinical and Translational Hepatology (JCTH) is owned by the Second Affiliated Hospital of Chongqing Medical University and published by XIA & HE Publishing Inc. JCTH publishes high quality, peer reviewed studies in the translational and clinical human health sciences of liver diseases. JCTH has established high standards for publication of original research, which are characterized by a study’s novelty, quality, and ethical conduct in the scientific process as well as in the communication of the research findings. Each issue includes articles by leading authorities on topics in hepatology that are germane to the most current challenges in the field. Special features include reports on the latest advances in drug development and technology that are relevant to liver diseases. Regular features of JCTH also include editorials, correspondences and invited commentaries on rapidly progressing areas in hepatology. All articles published by JCTH, both solicited and unsolicited, must pass our rigorous peer review process.

Follow us on X: 

Follow us on LinkedIn: 



Journal

Journal of Clinical and Translational Hepatology

DOI

10.14218/JCTH.2023.00290

Article Title

A Revised Classification of Primary Iron Overload Syndromes

Article Publication Date

19-Mar-2024

Share26Tweet16
Previous Post

Fixin’ to be flexitarian: Scrap fish and invasive species can liven up vegetables

Next Post

Innovative approach: KITECH suggests microplastic-free transparent mask

Related Posts

blank
Medicine

Tetraspanins: Key Players in Organ Fibrosis Therapy

September 28, 2025
blank
Medicine

Specialized Singing Programs Enhance Symptoms and Quality of Life for Individuals with Lung Disease

September 28, 2025
blank
Medicine

Factors Behind Nurse Migration: Insights from Iranian Students

September 28, 2025
blank
Medicine

Engineering Macrophages for Precision Cancer Therapy

September 28, 2025
blank
Medicine

Exploring Oral Health Challenges in Anorexia Nervosa

September 28, 2025
blank
Medicine

Nurses and Patients’ Views on ACS Treatment Adherence

September 28, 2025
Next Post
Innovative approach: KITECH suggests microplastic-free transparent mask

Innovative approach: KITECH suggests microplastic-free transparent mask

  • Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study

    Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study

    27560 shares
    Share 11021 Tweet 6888
  • University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept

    969 shares
    Share 388 Tweet 242
  • Bee body mass, pathogens and local climate influence heat tolerance

    646 shares
    Share 258 Tweet 162
  • Researchers record first-ever images and data of a shark experiencing a boat strike

    512 shares
    Share 205 Tweet 128
  • Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function

    471 shares
    Share 188 Tweet 118
Science

Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!

RECENT NEWS

  • Tetraspanins: Key Players in Organ Fibrosis Therapy
  • Post-Earthquake Trauma: Growth and PTSD Shape Youth Health
  • Remote Sensing Evaluates Ghana’s Mine Tailings Ponds
  • At-Home Monitoring Reduces Hospitalization Rates for Children with Asthma by 50%

Categories

  • Agriculture
  • Anthropology
  • Archaeology
  • Athmospheric
  • Biology
  • Blog
  • Bussines
  • Cancer
  • Chemistry
  • Climate
  • Earth Science
  • Marine
  • Mathematics
  • Medicine
  • Pediatry
  • Policy
  • Psychology & Psychiatry
  • Science Education
  • Social Science
  • Space
  • Technology and Engineering

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 5,184 other subscribers

© 2025 Scienmag - Science Magazine

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • HOME
  • SCIENCE NEWS
  • CONTACT US

© 2025 Scienmag - Science Magazine

Discover more from Science

Subscribe now to keep reading and get access to the full archive.

Continue reading